Shijie Ren

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

PharmacoEconomics

Health technology assessment (Winchester, England)

Research synthesis methods

Clinical journal of the American Society of Nephrology : CJASN

University of Sheffield (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Sheffield Oct 01 2007 - Sep 30 2011

United Kingdom

PHD :: SoMAS

University of York Sep 01 2003 - Jul 31 2006

United Kingdom

BSC :: Mathmatics

Publications

Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Shijie Ren, Sa Ren, Nicky J Welton, Mark Strong
Advancing unanchored simulated treatment comparisons: A novel implementation and simulation study. Research synthesis methods (2024)
Shijie Ren, Sa Ren, Nicky J Welton, Mark Strong
Advancing unanchored simulated treatment comparisons: A novel implementation and simulation study. Research synthesis methods 15 (4) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Andrew Metry, Abdullah Pandor, Shijie Ren, Andrea Shippam, Mark Clowes, Paul Dark, Ronan McMullan, Matthew D Stevenson
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis. Health technology assessment (Winchester, England) 27 (14) (2023)
Olena Mandrik, James Fotheringham, Shijie Ren, Jeffrey A Tice, Richard H Chapman, Matthew D Stevenson, Steven D Pearson, Serina Herron-Smith, Foluso Agboola, Praveen Thokala
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States. Clinical journal of the American Society of Nephrology : CJASN 17 (3) (2022)
Joanna Leaviss, Sarah Davis, Shijie Ren, Jean Hamilton, Alison Scope, Andrew Booth, Anthea Sutton, Glenys Parry, Marta Buszewicz, Rona Moss-Morris, Peter Denton White
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health technology assessment (Winchester, England) 24 (46) (2021)
Rose J Hart, Darren Burns, Bram L T Ramaekers, Shijie Ren, Daniel Gladwell, William G Sullivan, Niall J Davison, Owain Saunders, Indeg Sly, Theresa Cain, Dawn Lee
R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study. PharmacoEconomics 38 (7) (2021)
Shijie Ren, Hazel Squires, Emma Hock, Eva Kaltenthaler, Andrew Rawdin, Constantine Alifrangis
Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 37 (9) (2020)
Benjamin Kearns, John W Stevens, Shijie Ren, Alan Brennan
How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness. PharmacoEconomics 38 (2) (2020)
Shijie Ren, Jonathan Minton, Sophie Whyte, Nicholas R Latimer, Matt Stevenson
A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis. PharmacoEconomics 36 (3) (2019)
Shijie Ren, Iñigo Bermejo, Emma Simpson, Ruth Wong, David L Scott, Adam Young, Matt Stevenson
Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36 (7) (2019)

Shijie Ren.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shijie Ren